| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H35N3O2 |
| Molecular Weight | 409.5643 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@](C)(O)CC[C@H]34)[C@@H]1CC[C@@H]2C(=O)CN5C=C(C=N5)C#N
InChI
InChIKey=HARRKNSQXBRBGZ-GVKWWOCJSA-N
InChI=1S/C25H35N3O2/c1-24(30)9-7-18-17(11-24)3-4-20-19(18)8-10-25(2)21(20)5-6-22(25)23(29)15-28-14-16(12-26)13-27-28/h13-14,17-22,30H,3-11,15H2,1-2H3/t17-,18+,19-,20-,21+,22-,24-,25+/m1/s1
| Molecular Formula | C25H35N3O2 |
| Molecular Weight | 409.5643 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
|
|
ACTIVE MOIETY |
Indicated for the treatment of postpartum depression (PPD) in adults.
|
Showing 1 to 1 of 1 entries